Results 101 to 110 of about 20,250 (180)

Trametinib as second-line therapy for advanced KRAS G12C-mutant non-small cell lung cancer: a single-center clinical analysis of 20 cases. [PDF]

Front Med (Lausanne)
Wang X, Yu J.
europepmc   +1 more source

Correction to “Differential activity of MEK and ERK inhibitors in BRAF inhibitor resistant melanoma”

Molecular Oncology, Volume 20, Issue 8, Page 2129-2130, August 2026.
wiley   +1 more source

Successful rechallenge of BRAF/MEK inhibitor with ruxolitinib in BRAF/MEK inhibitor-induced hemophagocytic lymphohistiocytosis like hyperinflammatory syndrome in <i>BRAF</i> V600E-mutated lung adenocarcinoma: a case report. [PDF]

Front Oncol
Chandra S, Hansraj S, Adhikari A, Ponvilawan B, Tolentino A, Bansal D.   +5 more
europepmc   +1 more source

Case Report: Patient-derived organoids guiding dabrafenib-trametinib therapy in BRAF^V600E-mutant metastatic gastric cancer. [PDF]

Front Oncol
Gong C, Yang Y, Yan Q, Zhao W, Zhang M, Zhang W, You S, Yin R, Huang Y, Zhao Y, Zhou A.   +10 more
europepmc   +1 more source

Case Report: Erdheim-Chester disease with liver involvement successfully treated with trametinib. [PDF]

Front Oncol
Chang L, Shen KN, Luo YP, Cao XX.
europepmc   +1 more source

Expanding the Toolbox: Utility of HistioTrak for Minimal Residual Monitoring in Pediatric Patients with Langerhans Cell Histiocytosis Treated with Targeted Therapy. [PDF]

Cancers (Basel)
Nevers R, Rajbhandari A, Roeming D, Anthony A, Gibbs M, Ray AK.   +5 more
europepmc   +1 more source

Early-Onset Medullocervical Low-Grade Glioma With FGFR1 Mutation and Leptomeningeal Spread in an Infant: A Case Report. [PDF]

Clin Case Rep
Tumar TA, Suboh MW, Atatre MH, Shatrit H, Alnjoom QM.   +4 more
europepmc   +1 more source

Pathologic and radiologic response to neoadjuvant therapy in advanced differentiated thyroid cancer. [PDF]

Eur Thyroid J
Kampel L, Kampel L, Dorman A, Trejo LL, Krol K, Huber RK, Kravchenko Y, Antebi Y, Shendler G, Joshua BZ, Alon E, Warshavsky A, Horowitz G, Shilo S, Muhanna N, Finkel I.   +15 more
europepmc   +1 more source

Efficacy of azacitidine and trametinib against leptomeningeal melanosis associated with congenital melanocytic nevus syndrome. [PDF]

Mol Cell Pediatr
Raljević L, Komlosi K, Feige U, Eckenweiler M, Lassmann S, Jrad HBH, Werner M, Fischer J, Has C, Feuchtinger T, Uhl M, Niemeyer CM, Hettmer S.   +12 more
europepmc   +1 more source

Cutaneous Adverse Drug Reactions Associated With BRAF and MEK Inhibitors: A Real-World Analysis of WHO Pharmacovigilance Data. [PDF]

Clin Pharmacol Ther
Sauer N, Giedziun P, Calik J, Wiela-Hojeńska A.   +3 more
europepmc   +1 more source